In previous study, immunohistochemical analysis of HES6 mRNA and protein in human clinical samples 37 confirmed that HES6 was up-regulated in cancer and further demonstrated that strong nuclear HES6 protein expression increased as a function of Gleason grade, a potent indicator of metastatic potential in prostate cancer. Here, HES6 is linked to cancer.